12:00 AM
Sep 17, 2012
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Seprehvir: Phase I/IIa started

Virttu began an open-label, U.K. Phase I/IIa trial to evaluate single and multiple doses of intrapleural seprehvir in about 12 patients with inoperable...

Read the full 91 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >